GSK Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,934	3,397	3,870	2,936	3,723	4,274
Short-Term Investments	28	9	21	42	67	614
Trading Asset Securities	-	15	75	2,302	4,252	77
Cash & Short-Term Investments	2,962	3,421	3,966	5,280	8,042	4,965
Cash Growth	-10.41%	-13.74%	-24.89%	-34.34%	61.97%	-27.36%
Accounts Receivable	8,223	5,913	5,563	5,905	5,452	6,246
Other Receivables	302	1,450	1,365	1,489	1,652	1,214
Receivables	8,525	7,374	6,935	7,403	7,115	7,478
Inventory	6,300	5,924	5,669	5,498	5,146	5,783
Prepaid Expenses	-	385	390	355	343	315
Other Current Assets	108	406	37	108	123	133
Total Current Assets	17,895	17,510	16,997	18,644	20,769	18,674
Property, Plant & Equipment	10,122	10,048	10,073	9,957	9,620	10,672
Long-Term Investments	863	1,126	1,196	1,192	1,541	2,276
Goodwill	8,216	7,018	6,982	6,811	7,046	10,552
Other Intangible Assets	25,172	16,748	15,515	14,768	14,318	30,079
Long-Term Deferred Tax Assets	6,735	6,520	6,757	6,049	5,658	5,218
Other Long-Term Assets	2,696	2,148	1,943	1,584	1,194	1,632
Total Assets	71,699	61,118	59,463	59,005	60,146	79,103

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	15,633	3,535	3,462	3,718	3,866	4,535
Accrued Expenses	-	4,353	3,881	3,911	3,960	4,864
Short-Term Debt	253	1,078	-	815	1,489	707
Current Portion of Long-Term Debt	1,748	1,797	2,181	1,842	2,296	2,691
Current Portion of Leases	-	137	168	156	167	203
Current Income Taxes Payable	678	498	703	500	471	489
Current Unearned Revenue	-	153	171	222	299	307
Other Current Liabilities	2,408	9,840	11,131	9,904	10,262	9,874
Total Current Liabilities	20,720	21,391	21,697	21,068	22,810	23,670
Long-Term Debt	21,801	14,082	13,703	14,154	16,194	19,761
Long-Term Leases	-	693	934	1,051	841	812
Long-Term Unearned Revenue	-	121	165	254	83	85
Pension & Post-Retirement Benefits	1,552	1,687	1,864	2,340	2,579	3,113
Long-Term Deferred Tax Liabilities	1,670	291	382	311	289	3,556
Other Long-Term Liabilities	7,594	6,897	7,632	7,032	7,254	6,764
Total Liabilities	53,337	45,162	46,377	46,210	50,050	57,761

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,349	1,349	1,348	1,348	1,347	1,347
Additional Paid-In Capital	3,507	3,498	3,473	3,451	3,440	3,301
Retained Earnings	12,458	10,957	8,767	7,743	4,792	8,747
Comprehensive Income & Other	1,440	573	83	805	1,019	1,660
Total Common Equity	18,754	16,377	13,671	13,347	10,598	15,055
Minority Interest	-392	-421	-585	-552	-502	6,287
Shareholders' Equity	18,362	15,956	13,086	12,795	10,096	21,342
Total Liabilities & Equity	71,699	61,118	59,463	59,005	60,146	79,103

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	23,802	17,787	16,986	18,018	20,987	24,174
Net Cash (Debt)	-20,840	-14,366	-13,020	-12,738	-12,945	-19,209
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5.11	-3.49	-3.14	-3.10	-3.17	-4.74
Filing Date Shares Outstanding	4,009	4,013	4,081	4,056	4,034	4,007
Total Common Shares Outstanding	4,009	4,013	4,081	4,056	4,034	4,007
Working Capital	-2,825	-3,881	-4,700	-2,424	-2,041	-4,996
Book Value Per Share	4.68	4.08	3.35	3.29	2.63	3.76
Tangible Book Value	-14,634	-7,389	-8,826	-8,232	-10,766	-25,576
Tangible Book Value Per Share	-3.65	-1.84	-2.16	-2.03	-2.67	-6.38
Land	-	5,828	6,116	6,218	6,388	6,948
Machinery	-	11,133	10,641	10,344	10,481	11,302
Construction In Progress	-	2,508	2,314	2,092	1,808	1,707

SEC Filings: 10-K · 10-Q